Log In
Print
BCIQ
Print
Print this Print this
 

Restylane

  Manage Alerts
Collapse Summary General Information
Company Galderma S.A.
DescriptionHyaluronic acid dermal filler
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard Indication Dermatology (unspecified)
Indication DetailsLip augmentation
Regulatory Designation
Partner Ipsen Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$2,500.0M

$2,277.0M

$223.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today